Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials Group.
Year: 1996
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Journal of Clinical Oncology
Authors: J J Rusthoven, I C Quirt, N A Iscoe, P B McCulloch, K W James, R C Lohmann, J Jensen, S Burdette-Radoux, A J Bodurtha, H K Silver, S Verma, G R Armitage, B Zee, K Bennett
Institution: Hamilton Health Sciences
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1752324982
